Skip to main content

Table 2 Summary assessment of the risk of bias for included RCTs using the revised Cochrane risk of bias tool for randomized trials (RoB2)

From: Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis

Author (publication year)

Randomization

Deviations from intended intervention

Missing outcome data

Measurement of the outcome

Selection of the reported results

Overall

Lucci et al. 2007, Giuliano et al. 2010, Giuliano et al. 2011, and Giuliano et al. 2017, ACOSOG Z0011 [12, 30, 33, 42]

Galimberti et al. 2013 and Galimberti et al. 2018, IBCSG 23–01 [13, 43]

Sola et al. 2013, AATRM 048/13/2000 [36]

Bartels et al. (2022)

EORTC 10981–22023 AMAROS Trial [53]

Tinterri et al. (2022)

SINODAR-ONE trial [56]

  1. Notes: Low risk of bias, High risk of bias, Some concerns